NDC 13672-054

Betapace AF

Sotalol Hcl

Betapace AF is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Skyepharma Production Sas. The primary component is Sotalol Hydrochloride.

Product ID13672-054_754a6348-953f-4e8e-e053-2991aa0adde2
NDC13672-054
Product TypeHuman Prescription Drug
Proprietary NameBetapace AF
Generic NameSotalol Hcl
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2000-02-22
Marketing CategoryNDA / NDA
Application NumberNDA021151
Labeler NameSkyePharma Production SAS
Substance NameSOTALOL HYDROCHLORIDE
Active Ingredient Strength80 mg/80mg
Pharm ClassesAntiarrhythmic [EPC],Cardiac Rhythm Alteration [PE],Adrenergic beta-Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 13672-054-00

60 mg in 1 BOTTLE (13672-054-00)
Marketing Start Date2000-02-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13672-054-00 [13672005400]

Betapace AF TABLET
Marketing CategoryNDA
Application NumberNDA021151
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2000-02-22

Drug Details

Active Ingredients

IngredientStrength
SOTALOL HYDROCHLORIDE80 mg/80mg

Pharmacological Class

  • Antiarrhythmic [EPC]
  • Cardiac Rhythm Alteration [PE]
  • Adrenergic beta-Antagonists [MoA]

NDC Crossover Matching brand name "Betapace AF" or generic name "Sotalol Hcl"

NDCBrand NameGeneric Name
13672-054Betapace AFsotalol HCl
13672-055Betapace AFsotalol HCl
13672-056Betapace AFsotalol HCl
70515-115BETAPACE AFsotalol hydrochloride
70515-116BETAPACE AFsotalol hydrochloride
70515-119BETAPACE AFsotalol hydrochloride
13672-051Betapacesotalol HCl
13672-052Betapacesotalol HCl
13672-053Betapacesotalol HCl

Trademark Results [Betapace AF]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BETAPACE AF
BETAPACE AF
75817196 2711659 Live/Registered
COVIS PHARMA B.V.
1999-10-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.